Learn More
Invitrogen™ ENO1/2/3 Recombinant Rabbit Monoclonal Antibody (K01_1Q80)
Description
ENO1/2/3 Recombinant Monoclonal Antibody for Western Blot
Specifications
Specifications
| Antigen | ENO1/2/3 |
| Applications | Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | K01_1Q80 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 50mM tris glycine with 40% glycerol, 0.05% BSA, 150mM NaCl and 0.01% sodium azide; pH 7.4 |
| Gene | ENO1 |
| Gene Accession No. | P04764, P06733, P07323, P09104, P13929, P15429, P17182, P17183, P21550 |
| Gene Alias | 0610008I15; 2-phospho-D-glycerate hydrolase; 2-phospho-D-glycerate hydrolyase; 2-phospho-D-glycerate hydro-lyase; AI837106; AL022784; alpha enolase; alpha enolase like 1; alpha-enolase; alpha-enolase; c-myc promoter-binding protein-1; BBE; beta-enolase; c-Myc promoter binding protein; C-myc promoter-binding protein; D6Ertd375e; Eno1; Eno-1; ENO1L1; ENO2; Eno-2; Eno3; Eno-3; Enolase 1; enolase 1, (alpha); enolase 1, alpha non-neuron; enolase 2; enolase 2 (gamma, neuronal); enolase 2, gamma neuronal; enolase 2, gamma, neuronal; enolase 3; enolase 3 (beta, muscle); enolase 3, beta muscle; enolase 3, beta, muscle; enolase-alpha; epididymis secretory protein Li 17; epididymis secretory protein Li 279; gamma-enolase; GSD13; HEL-S-17; HEL-S-279; MBP-1; MBPB1; MPB1; MPB-1; MSE; muscle enriched enolase; Muscle specific enolase (beta beta enolose) (two splicing products); muscle-specific enolase; MYC promoter-binding protein 1; neural enolase; neuron specific gamma enolase; neuronal enriched enolase; neurone-specific enolase; neuron-specific enolase; NNE; Non-neural enolase; NSE; Phosphopyruvate hydratase; plasminogen-binding protein; PPH; RNEN3; Skeletal muscle enolase; tau-crystallin |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.